Innovation Medical(002173)
Search documents
股价大涨,创新医疗称博灵脑机产品尚未正式上市
Bei Jing Shang Bao· 2025-08-13 11:31
Group 1 - The core point of the article is that Innovation Medical's stock experienced a significant price fluctuation, with a cumulative increase of over 20% in three consecutive trading days [1] - Innovation Medical announced its investment in Bole Brain Machine (Hangzhou) Technology Co., Ltd., holding a 40% stake in the company [1] - Bole Brain Machine focuses on the research and development of core brain-machine interface technologies and related product design and production, primarily targeting the medical rehabilitation sector [1] Group 2 - As of the announcement date, Bole Brain Machine's products have not been officially launched, and only a small number of products have been sold through collaborations with research institutions [1] - The operating losses for Bole Brain Machine are projected to be 6.6017 million yuan in 2023 and 8.6641 million yuan in 2024 [1]
龙虎榜复盘 | 军工高度继续打开,算力全线大涨
Xuan Gu Bao· 2025-08-13 11:15
龙虎榜机构热股 今天机构龙虎榜上榜40只个股,净买入28只,净卖出12只。当日机构买入最多的个股前三位是:沪电股份(1.03亿)、创新 医疗(1.01亿)、江特电机(8933万)。 安徽省国资委旗下,公司为老牌弹药供应商 内蒙一机 | 上榜热股 | | 实时涨跌幅 ; 买/卖家数 , 机构净买额 ; | | | --- | --- | --- | --- | | 沪电股份 | +10.00% | 3/4 | +1.03亿 | | 002463.SZ | | | | | 创新医疗 | | | | | 002173.SZ | +10.00% | 2/1 | +1.01亿 | | 3日 | | | | | 江特电机 | | | | | 002176.SZ | +1.99% | 2/0 | +8933.17万 | | 3日 | | | | 沪电股份 龙虎榜显示,今日3家机构净买入1.03亿。 龙虎榜知名游资 一、军工 长城军工 个股龙虎榜 罗博特科 个股龙虎榜 参股公司ficonTEC是光电子封测行业重要的设备提供商,为光芯片、光电子器件及光模块的自动化微组装、耦合以及测试市 场客户提供高精度自动化设备和相关技术服务 ...
创新医疗:博灵脑机产品尚未正式上市 仅因与科研机构合作而销售少量产品
Zhi Tong Cai Jing· 2025-08-13 10:36
创新医疗(002173)(002173.SZ)发布股价异动公告称,公司2021年初参与投资设立了博灵脑机(杭州)科 技有限公司(简称"博灵脑机"),公司持有博灵脑机40%的股权。博灵脑机主要从事脑机接口核心技术研 发和相关产品的设计生产,现阶段的技术产品主要应用于医疗康复领域。截止公告日,博灵脑机产品尚 未正式上市,仅因与科研机构合作而销售少量产品。2023年、2024年,博灵脑机的经营亏损分别为 660.17万元、866.41万元。 ...
创新医疗(002173.SZ):博灵脑机产品尚未正式上市 仅因与科研机构合作而销售少量产品
智通财经网· 2025-08-13 10:33
智通财经APP讯,创新医疗(002173.SZ)发布股价异动公告称,公司2021年初参与投资设立了博灵脑机 (杭州)科技有限公司(简称"博灵脑机"),公司持有博灵脑机40%的股权。博灵脑机主要从事脑机接口核 心技术研发和相关产品的设计生产,现阶段的技术产品主要应用于医疗康复领域。截止公告日,博灵脑 机产品尚未正式上市,仅因与科研机构合作而销售少量产品。2023年、2024年,博灵脑机的经营亏损分 别为660.17万元、866.41万元。 ...
创新医疗:公司持有博灵脑机40%的股权 博灵脑机2023年和2024年经营亏损分别为660.17万元和866.41万元
Mei Ri Jing Ji Xin Wen· 2025-08-13 10:32
Core Viewpoint - The stock of Innovation Medical experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from August 11 to August 13, 2025, but no undisclosed significant information affecting the stock price was found [1] Group 1 - The company confirmed that there were no significant changes in its production operations or external environment, and the controlling shareholder and actual controller did not plan any undisclosed major matters during the abnormal fluctuation period [1] - Innovation Medical holds a 40% stake in Bole Brain Machine (Hangzhou) Technology Co., Ltd., which focuses on the research and development of core brain-machine interface technologies and related product design and production [1] - Bole Brain Machine's products are primarily applied in the medical rehabilitation field, but as of the announcement date, the products have not been officially launched, with only a small number of products sold through collaboration with research institutions [1] Group 2 - The operating losses for Bole Brain Machine were reported at 6.6017 million yuan in 2023 and 8.6641 million yuan in 2024 [1]
创新医疗(002173) - 股票交易异常波动公告
2025-08-13 10:32
证券代码:002173 证券简称:创新医疗 公告编号:2025-051 创新医疗管理股份有限公司 股票交易异常波动公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 6、公司控股股东及实际控制人在本公司股票交易异常波动期间未买卖本公 司股票。 三、是否存在应披露而未披露信息的说明 一、股票交易异常波动的情况介绍 公司股票(证券简称:创新医疗,股票代码:002173)于2025年8月11日、 12日、13日连续三个交易日内日收盘价格涨幅偏离值累计超过20%,根据《深圳 证券交易所交易规则》的有关规定,公司股票属于交易异常波动的情形。 二、公司关注、核实情况的说明 针对公司股票交易异常波动情况,公司对控股股东及实际控制人、公司董事、 监事及高级管理人员就相关问题进行了核实,现将有关情况说明如下: 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生 较大影响的未公开重大信息。 3、近期公司生产经营情况及内外部经营环境未发生重大变化。 4、公司、控股股东及实际控制人不存在应披露而未披露的重大事项,也不 ...
创新医疗股价涨停 脑机接口政策助力行业突破
Sou Hu Cai Jing· 2025-08-13 09:36
截至2025年8月13日收盘,创新医疗股价报22.65元,较前一交易日上涨10.00%。当日成交金额达31.96 亿元,换手率为35.29%。 风险提示:以上内容仅供参考,不构成投资建议。市场有风险,投资需谨慎。 来源:金融界 创新医疗主营业务为医疗服务,涉及脑机接口等前沿技术领域。公司最新市值为99.95亿元,流通市值 94.29亿元。 消息面上,工信部等七部门近日联合印发《关于推动脑机接口产业创新发展的实施意见》,提出到2027 年实现关键技术重大突破,并在医疗健康等领域加快落地应用。该政策对创新医疗等脑机接口概念股形 成直接利好。 ...
龙虎榜丨机构今日抛售这14股,买入创新医疗1.01亿元





Di Yi Cai Jing· 2025-08-13 09:33
। บ.บ । /บ UU I I I I I I I r - Trim H - W 中欣氟材 -7697.17 6.49% 班 빵 服 第□财经 当天机构净卖出前三的股票分别是中欣氟材、博威合金、中国长城,净流出金额分别是7697万元、6341万元、 6079万元。 | | 龙虎榜榜08.13 | F | | --- | --- | --- | | 证券简称 | 目涨跌幅 | 机构净买入 (万元) | | 创新医疗 | 10.00% | 10079.77 | | 江特电机 | 1.99% | 8933.17 | | 沪电股份 | 10.00% | 7292.01 | | 罗博特科 | 20.00% | 6905.96 | | 北纬科技 | 10.04% | 4191.31 | | 威尔高 | 6.99% | 4175.57 | | 中船特气 | 20.01% | 3763.92 | | 东方精工 | 10.03% | 2724.97 | | 恒信东方 | -18.83% | 2691.15 | | 浙江华小 | 2.73% | 1643.22 | | --- | --- | --- | | 麦澜德 | -3 ...
创新医疗龙虎榜数据(8月13日)
Zheng Quan Shi Bao Wang· 2025-08-13 08:55
Core Viewpoint - Innovation Medical experienced a significant trading surge, with a daily turnover rate of 35.29% and a transaction volume of 3.196 billion yuan, indicating strong market interest and activity [2] Trading Activity - The stock reached its daily limit, with a turnover rate of 35.29% and a trading volume of 3.196 billion yuan, showing a price fluctuation of 9.63% throughout the day [2] - Institutional investors net bought 101 million yuan, while brokerage seats collectively net bought 26.39 million yuan [2] - The stock was listed on the Dragon and Tiger list due to its high turnover rate, with institutional proprietary seats contributing a net purchase of 101 million yuan [2] Institutional Participation - The top five trading departments accounted for a total transaction volume of 844 million yuan, with a buying volume of 486 million yuan and a selling volume of 359 million yuan, resulting in a net purchase of 127 million yuan [2] - Among the trading departments, three institutional proprietary seats were active, with total buying amounts of 291 million yuan and selling amounts of 190 million yuan, leading to a net purchase of 101 million yuan [2] Historical Performance - Over the past six months, the stock has appeared on the Dragon and Tiger list 11 times, with an average price increase of 2.30% the day after being listed and an average increase of 11.25% over the following five days [2] Capital Flow - Despite the day's strong trading activity, the stock saw a net outflow of 57.08 million yuan in main funds, with large orders contributing to a net outflow of 33.10 million yuan and 23.98 million yuan respectively [2] - In the past five days, the main funds have seen a net inflow of 486 million yuan [2]
医疗服务板块8月13日涨4.02%,创新医疗领涨,主力资金净流入19.62亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-13 08:41
Market Performance - On August 13, the medical services sector rose by 4.02%, led by Innovative Medical [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - The table lists various stocks in the medical services sector, with notable declines including *ST Bio down 4.95% and ST Zhongzhu down 2.66% [1] - Other stocks such as Lanwei Medical and Baicheng Pharmaceutical also experienced minor declines of 1.76% and 1.59% respectively [1] Capital Flow Analysis - The medical services sector saw a net inflow of 1.962 billion yuan from institutional investors, while retail investors experienced a net outflow of 1.888 billion yuan [3] - Notable stocks with significant net inflows from institutional investors include Yaoming Kande with 1.13 billion yuan and Kanglong Huacheng with 248 million yuan [3] - Conversely, retail investors showed significant outflows from stocks like Yaoming Kande and Kanglong Huacheng, indicating a shift in investor sentiment [3]